The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage

Respiratory Medicine

Volumn 95, Issue 2, 2001, Pages 130-135

  Takahashi, T ^a   Yamaguchi, E ^a   Furuya, K ^a   Kawakami, Y ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ACE gene polymorphism; ACE inhibitor; Bradykinin; Cough; Substance P

Indexed keywords

BRADYKININ; CAPSAICIN; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; PLACEBO; SUBSTANCE P;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; DRUG USE; ENZYME SUBSTRATE; FEMALE; GENE ACTIVITY; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; IMMUNOMODULATION; INCIDENCE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; TISSUE LEVEL;

EID: 0034942087     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.1005     Document Type: Article

References (36)

1. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy
2. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough
3. Change in cough reflex after treatment with enalapril and ramipril
4. Cough associated with captopril and enalapril
5. Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs
6. Neutral endopeptidase inhibitors potentiate substance P- and capsaicin-induced cough in awake guinea pigs
7. Angiotensin-converting enzyme and the cough reflex
8. The positive association of cough with angiotensin converting enzyme inhibitors
9. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation
10. Cough associated with the use of captopril
11. Effects of intradermal bradykinin after inhibition of angiotension converting enzyme
12. The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients
13. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
14. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
15. Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough
16. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase 1)
17. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough
18. Colorimetry of angiotensin-I converting enzyme activity in serum
19. Blood kinin measurement by sensitive kinin radioimmunoassay and its clinical application
20. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides
21. Resolution of ACE inhibitor cough: Changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P
22. Angiotensin-converting enzyme inhibitor and danazol increase sensitivity of cough reflex in female guinea pigs
23. Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig
24. Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P
25. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor
26. Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough
27. The Kallikrein-kinin system and angiotensin converting enzyme inhibition in hypertension
28. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels
29. Angiotensin-converting enzyme inhibition, cough and the serum concentration of substance P
30. The effect of inhalations of bradykinin on healthy and atopic (asthmatic) children
31. Sequence variation in the human angiotensin converting enzyme
32. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis
33. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: Evidence for two quantitative-trait loci
34. ACE inhibitors, cough, and genetics
35. ACE inhibitors, cough, and genetics
36. Three candidate genes and angiotensin-converting enzyme inhibitor-related cough